Schrader A - Search Results

1

Detection of melanoma cells in peripheral blood stem cell harvests of patients with progressive metastatic malignant melanoma.

Probst-Kepper M, Schrader A, Buer J, Grosse J, Volkenandt M, Illiger HJ, Metzner B, Kadar J, Duensing S, Hertenstein B, Ganser A, Atzpodien J. Probst-Kepper M, et al. Among authors: schrader a. Br J Haematol. 1997 Aug;98(2):488-90. doi: 10.1046/j.1365-2141.1997.1963015.x. Br J Haematol. 1997. PMID: 9266956 Free article.

2

Molecular and prognostic classification of advanced melanoma: a multi-marker microcontamination assay of peripheral blood stem cells.

Schrader AJ, Probst-Kepper M, Grosse J, Kunter U, Schenk F, Franzke A, Atzpodien J, Buer J. Schrader AJ, et al. Melanoma Res. 2000 Aug;10(4):355-62. doi: 10.1097/00008390-200008000-00007. Melanoma Res. 2000. PMID: 10985670

3

High-dose chemotherapy with autologous stem-cell transplantation in patients with pretreated advanced malignant melanoma.

Schrader AJ, Atzpodien J. Schrader AJ, et al. Ann Oncol. 2000 Oct;11(10):1361-2. doi: 10.1023/a:1008300122227. Ann Oncol. 2000. PMID: 11106128 Free article. No abstract available.

4

Tumour microdissemination and survival in metastatic melanoma.

Schrader AJ, Probst-Kepper M, Grosse J, Kunter U, Franzke A, Sel S, Atzpodien E, Buer J. Schrader AJ, et al. Anticancer Res. 2000 Sep-Oct;20(5B):3619-24. Anticancer Res. 2000. PMID: 11131671

5

Tumor markers in peripheral blood of patients with malignant melanoma: multimarker RT-PCR versus a luminoimmunometric assay for S-100.

Berking C, Schlüpen EM, Schrader A, Atzpodien J, Volkenandt M. Berking C, et al. Among authors: schrader a. Arch Dermatol Res. 1999 Sep;291(9):479-84. doi: 10.1007/s004030050441. Arch Dermatol Res. 1999. PMID: 10541877

6

Capecitabine in the treatment of metastatic renal cell carcinoma.

Oevermann K, Buer J, Hoffmann R, Franzke A, Schrader A, Patzelt T, Kirchner H, Atzpodien J. Oevermann K, et al. Among authors: schrader a. Br J Cancer. 2000 Sep;83(5):583-7. doi: 10.1054/bjoc.2000.1340. Br J Cancer. 2000. PMID: 10944596 Free PMC article. Clinical Trial.

7

HLA phenotype and cytokine-induced tumor control in advanced renal cell cancer.

Franzke A, Buer J, Probst-Kepper M, Lindig C, Framzle M, Schrader AJ, Ganser A, Atzpodien J. Franzke A, et al. Among authors: schrader aj. Cancer Biother Radiopharm. 2001 Oct;16(5):401-9. doi: 10.1089/108497801753354302. Cancer Biother Radiopharm. 2001. PMID: 11776757

8

CXCR4/CXCL12 expression and signalling in kidney cancer.

Schrader AJ, Lechner O, Templin M, Dittmar KE, Machtens S, Mengel M, Probst-Kepper M, Franzke A, Wollensak T, Gatzlaff P, Atzpodien J, Buer J, Lauber J. Schrader AJ, et al. Br J Cancer. 2002 Apr 22;86(8):1250-6. doi: 10.1038/sj.bjc.6600221. Br J Cancer. 2002. PMID: 11953881 Free PMC article.

9

RAR-beta(1) overexpression in chromophobe renal cell carcinoma: a novel target for therapeutic intervention?

Goelden U, Ukena SN, Pfoertner S, Hofmann R, Buer J, Schrader AJ. Goelden U, et al. Among authors: schrader aj. Exp Oncol. 2005 Sep;27(3):220-4. Exp Oncol. 2005. PMID: 16244585

10

[Application monitoring of the use of sorafenib in papillary renal cell carcinoma].

Schrader AJ, Hegele A, Olbert P, Buer J, Jeron A, Hofmann R. Schrader AJ, et al. Urologe A. 2007 Sep;46(9):1291. doi: 10.1007/s00120-007-1500-9. Urologe A. 2007. PMID: 17668165 German. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

465 results

Search Page

Filters